Results 201 to 210 of about 133,411 (313)

Evaluating Bacillus Calmette-Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice. [PDF]

Influenza Other Respir Viruses
Yan S, Yang F, Ji J, Lin X, Wang P, Wu H, Cheng L, Liu F, Wu N, Yao H, Wu WSJ, Wu H.   +11 more
europepmc   +1 more source

Global Interdependence, Just Vaccine Allocation, and Compensatory Justice: A New Model

Developing World Bioethics, EarlyView.
ABSTRACT During the COVID‐19 pandemic, numerous models were offered for how scarce vaccine resources should be distributed. Proposed vaccine distribution models generally were divided between nationalist models, which give preference to nationals, and cosmopolitan models, which ignore national boundaries.
Kalen J. Fredette
wiley   +1 more source

Multivalent COBRA Hemagglutinin and Neuraminidase Influenza Vaccines Adjuvanted with TLR9 Agonist CpG 1018. [PDF]

Vaccines (Basel)
Sanchez PL, Lynch A, Ross TM.
europepmc   +1 more source

Harnessing controlled human infection models to accelerate vaccine development for neglected tropical diseases: Lessons from leishmaniasis

European Journal of Clinical Investigation, EarlyView.
Controlled Human Infection Models (CHIMs) offer a powerful approach to accelerate vaccine development for neglected tropical diseases (NTDs). This review highlights scientific and translational advances enabled by CHIMs, with a focus on a novel Leishmania major model.
Vivak Parkash
wiley   +1 more source

Estimated Relative Effectiveness and Public Health Impact of Cell-Based Versus Egg-Based Influenza Vaccines During the 2022-2023 Season in the United States. [PDF]

Influenza Other Respir Viruses
Stein AN, Thanataveerat A, McDermott KW, Dean A, Wall S, Pack C, Sullivan SG, McGovern I, Haag MDM.   +8 more
europepmc   +1 more source

Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine

, 2004
Kyoko Shinya, Yutaka Fujii, Hiroshi Ito, Toshihiro Ito, Yoshihiro Kawaoka   +4 more
openalex   +1 more source

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies

European Journal of Haematology, EarlyView.
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 Season. [PDF]

Influenza Other Respir Viruses
Bricout H, Levant MC, Crépey P, Gavazzi G, Gaillat J, Dufournet M, Assi N, Grenier B, Raguideau F, Péretz F, Salamand C, Mosnier A, Watier L, Launay O, Loiacono MM.   +14 more
europepmc   +1 more source

Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial

Dan Wu, Chenqi Jin, Khaoula Bessame, Fanny Fong-Yi Tang, Jason J. Ong, Zaisheng Wang, Yewei Xie, Mark Jit, Heidi J. Larson, Tracey Chantler, Leesa Lin, Wenfeng Gong, Fan Yang, Fengshi Jing, Shufang Wei, Weibin Cheng, Yi Zhou, Nina Ren, Shuhao Qiu, Jianmin Bao, Liufen Wen, Qinlu Yang, Junzhang Tian, Weiming Tang, Joseph D. Tucker   +24 more
openalex   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source